Featured solutions for Cancer Research
PerkinElmer is committed to helping you explore and unravel the complexities of cancer and translate your findings into more effective treatments with a diverse range of solutions.
 Leveraging TCGA Database For Oncology ResearchThe ability to access and search across public genome datasets efficiently, can have tremendous impact on biomarker discovery. Simplify the complexity around search, retrieval and analysis of large public datasets such as The Cancer Genome Atlas (TCGA) to gain valuable insights for Oncology biomarker detection. |
 GenomicsOur genomics solutions for cancer research cover multiple applications including; NGS sequencing, PCR analysis, CRISPR analysis, and more. Our broad range of solutions are designed to improve the efficiency of your cancer research workflows. |
 Assay Technologies & Multimode Plate ReadersWhether your cancer research encompasses biomarker discovery, cell-signaling, GPCR research, or protein interaction, our assay technologies multimode plate readers can help advance your cancer research and discovery. |
 Cell Imaging SolutionsWhether you’re trying to better understand biological processes in cancer cells or investigating how drugs affect those processes, our cell imaging solutions allow you to gain deeper insights from physiologically-relevant model systems. |
 In Vivo ImagingDeepen your understanding of the mechanisms underlying tumor biology, quantify tumor volume, monitor tumor growth and progression, visualize tumor vascularity, or evaluate cancer therapies in the context of the whole animal with our in vivo imaging solutions.
Product Highlights |
 NexcelomCell counters and image cytometers are critical for all your immuno-oncology research, whether you need to perform cell-based assays and measure cell size, automatically quantify cell viability and concentration, or need accurate cell counting methods for CAR-T therapy, Nexcelom cellometers and cytometers provide you quality results. |
 BiolegendBioLegend provides solutions for advancing all aspects of cancer research, from elucidating the basic science of tumorigenesis to the development of novel immunotherapies. Find antibodies, multiplex assays, in vivo reagents, and resources to investigate individual research areas or connect multiple concepts. |
 HorizonHorizon drives the application of gene editing and gene modulation to enable identification of genetic drivers behind human disease, develop and validate diagnostic workflows, and deliver new therapies for precision medicine. Researchers can access CRISPR-based tools for knock-in, knockout, and modulation as well as RNAi and overexpression products by Dharmacon™. As an alternative to readily available do-it-yourself products, Horizon provides high-throughput screening and cell line engineering services allowing researchers to save valuable lab time and internal resources while obtaining quality results. Building on extensive expertise in gene editing, Horizon continues to develop new and emerging technologies. This includes a cell line-derived reference standard portfolio and the CHOSOURCE™ platform for biotherapeutic manufacturing. |
 Sirion BiotechSIRION Biotech designs and manufactures viral vectors for cell and gene therapy research and preclinical development. We have active R&D in the areas of AAV and LV vector optimization focused on clinically compliant vector designs, plus upstream and downstream process development for AAV, AV, and Lentivirus manufacture. |
 Omni InternationalOmni International, a PerkinElmer company, with headquarters in Kennesaw Georgia, is a leading global manufacturer and distributor of laboratory homogenizers. OMNI sets the industry standard with an unmatched commitment to outstanding product design, reliable performance and a uniquely diversified solution based product line. Since 1956, the name OMNI has been synonymous with laboratory homogenizers. Referenced in over 10,000 peer reviewed scientific articles, OMNI homogenizers can be found in laboratories worldwide and are counted on for years of trouble-free operation. |